Amit Hazan
Stock Analyst at Goldman Sachs
(2.14)
# 2,892
Out of 5,165 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $55.15 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $8.99 | -72.19% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.17 | +1,523.93% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $13.85 | -42.24% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $62.43 | +0.91% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $161.64 | +68.28% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $16.71 | +1.74% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $3.61 | +11,949.86% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $27.36 | +60.82% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $84.27 | -13.37% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $17.62 | +200.79% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $23.46 | +142.97% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $13.05 | -27.20% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $110.71 | -6.06% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $18.09 | +231.67% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $88.44 | +30.03% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $349.11 | -57.03% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $71.20 | -35.39% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $482.76 | -49.94% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $92.52 | +91.31% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $238.11 | -38.26% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.39 | +896.68% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $55.15
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $8.99
Upside: -72.19%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.17
Upside: +1,523.93%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $13.85
Upside: -42.24%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $62.43
Upside: +0.91%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $161.64
Upside: +68.28%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $16.71
Upside: +1.74%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $3.61
Upside: +11,949.86%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $27.36
Upside: +60.82%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $84.27
Upside: -13.37%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $17.62
Upside: +200.79%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $23.46
Upside: +142.97%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $13.05
Upside: -27.20%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $110.71
Upside: -6.06%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $18.09
Upside: +231.67%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $88.44
Upside: +30.03%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $349.11
Upside: -57.03%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $71.20
Upside: -35.39%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $482.76
Upside: -49.94%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $92.52
Upside: +91.31%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $238.11
Upside: -38.26%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.39
Upside: +896.68%